Skip to main content
. 2016 Apr 8;8(10):499–508. doi: 10.4254/wjh.v8.i10.499

Table 2.

Patient characteristics

Factor Cirrhosis with acute decompensation from etiologies other than alcohol (n = 23)
Alcoholic hepatitis (n = 25)
P-value
n Summary n Summary
Age (yr) 14 53.8 ± 9.8 20 51.5 ± 10.4 0.511
Male 21 13 (61.9) 23 10 (43.5) 0.223
Caucasian 10 10 (100.0) 19 16 (84.2) 0.534
AST 23 40.0 (33.0, 75.0) 25 138.0 (88.0, 161.0) < 0.0012b
ALT 23 21.0 (15.0, 30.0) 25 51.0 (42.0, 71.0) < 0.0012b
Bilirubin 23 3.8 (1.4, 6.0) 25 9.4 (6.8, 21.7) 0.0052b
Albumin 23 2.8 ± 0.66 25 2.8 ± 0.68 0.861
INR 23 1.5 ± 0.41 25 1.7 ± 0.59 0.161
PT 23 16.4 ± 4.5 25 19.1 ± 6.1 0.0951
Creatinine 23 0.94 (0.74, 1.5) 25 0.72 (0.57, 1.04) 0.0622
MELD score 23 16.4 ± 8.8 25 20.5 ± 10.0 0.141
Maddrey's score 16 22.2 (16.0, 37.0) 17 43.5 (34.0, 60.6) 0.0282a
Ascites 23 25 0.142
None 9 (39.1) 14 (56.0)
Small 4 (17.4) 6 (24.0)
Large 9 (39.1) 4 (16.0)
Severe 1 (4.3) 1 (4.0)
HE 23 25 0.942
None 2 (8.7) 6 (24.0)
Mild 12 (52.2) 7 (28.0)
Severe 9 (39.1) 12 (48.0)
Steroids 23 2 (8.7) 25 13 (52.0) 0.0013b
Trental 23 3 (13.0) 25 9 (36.0) 0.0673
OLT 23 2 (8.7) 25 1 (4.0) 0.604
Deceased 23 6 (26.1) 25 8 (32.0) 0.653

P-values were calculated using the test corresponding to superscript characters:

1

ANOVA;

2

Kruskal-Wallis test;

3

Pearson’s χ2 test;

4

Fisher’s exact test.

a

P < 0.05 and

b

P < 0.01. AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; MELD: Model for end-stage liver disease; OLT: Orthotopic liver transplantation; PT: Prothrombin time; INR: International normalized ratio; HE: Hepatic encephalopathy.